AU2002217795A1 - Isolation procedure and optimized media solution to enhance long-term survival of cells - Google Patents

Isolation procedure and optimized media solution to enhance long-term survival of cells

Info

Publication number
AU2002217795A1
AU2002217795A1 AU2002217795A AU1779502A AU2002217795A1 AU 2002217795 A1 AU2002217795 A1 AU 2002217795A1 AU 2002217795 A AU2002217795 A AU 2002217795A AU 1779502 A AU1779502 A AU 1779502A AU 2002217795 A1 AU2002217795 A1 AU 2002217795A1
Authority
AU
Australia
Prior art keywords
cells
term survival
isolation procedure
media solution
enhance long
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002217795A
Inventor
Federica Del Monte
Judith K. Gwathmey
Georges E. Haddad
Roger J. Hajjar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gwathmey Inc
Original Assignee
Gwathmey Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gwathmey Inc filed Critical Gwathmey Inc
Publication of AU2002217795A1 publication Critical patent/AU2002217795A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002217795A 2000-11-22 2001-11-21 Isolation procedure and optimized media solution to enhance long-term survival of cells Abandoned AU2002217795A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25265700P 2000-11-22 2000-11-22
US60/252,657 2000-11-22
PCT/US2001/043572 WO2002042431A2 (en) 2000-11-22 2001-11-21 Isolation procedure and optimized media solution to enhance long-term survival of cells

Publications (1)

Publication Number Publication Date
AU2002217795A1 true AU2002217795A1 (en) 2002-06-03

Family

ID=22956960

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002217795A Abandoned AU2002217795A1 (en) 2000-11-22 2001-11-21 Isolation procedure and optimized media solution to enhance long-term survival of cells

Country Status (3)

Country Link
US (1) US20020110910A1 (en)
AU (1) AU2002217795A1 (en)
WO (1) WO2002042431A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003096972A2 (en) * 2002-05-13 2003-11-27 Massachusetts Institute Of Technology Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
US7840263B2 (en) 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US7764995B2 (en) * 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US7729761B2 (en) * 2004-07-14 2010-06-01 Cardiac Pacemakers, Inc. Method and apparatus for controlled gene or protein delivery
US7828711B2 (en) * 2004-08-16 2010-11-09 Cardiac Pacemakers, Inc. Method and apparatus for modulating cellular growth and regeneration using ventricular assist device
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
US8060219B2 (en) 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US7548780B2 (en) * 2005-02-22 2009-06-16 Cardiac Pacemakers, Inc. Cell therapy and neural stimulation for cardiac repair
US20070003528A1 (en) 2005-06-29 2007-01-04 Paul Consigny Intracoronary device and method of use thereof
US20070036770A1 (en) * 2005-08-12 2007-02-15 Wagner Darrell O Biologic device for regulation of gene expression and method therefor
US7774057B2 (en) * 2005-09-06 2010-08-10 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression for cardiac protection
US20080076836A1 (en) * 2006-09-01 2008-03-27 Cardiac Pacemakers, Inc Method and apparatus for using light to enhance cell growth and survival
WO2008103336A1 (en) * 2007-02-21 2008-08-28 Cook Incorporated Methods for intravascular engraftment in heart
DE102010034330B4 (en) 2010-08-14 2013-10-31 Cytonet Gmbh & Co. Kg Process for the preparation of disinfected human cell suspensions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999023880A1 (en) * 1997-11-07 1999-05-20 Johns Hopkins University Somatic transfer of modified genes to predict drug effects
US6635249B1 (en) * 1999-04-23 2003-10-21 Cenes Pharmaceuticals, Inc. Methods for treating congestive heart failure

Also Published As

Publication number Publication date
WO2002042431A2 (en) 2002-05-30
US20020110910A1 (en) 2002-08-15
WO2002042431A3 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
AU7813401A (en) Isolation and use of solid tumor stem cells
AU2002217795A1 (en) Isolation procedure and optimized media solution to enhance long-term survival of cells
AU2001274624A1 (en) Cell fraction containing cells capable of differentiating into nervous system cells
AU1824600A (en) Low oxygen culturing of cells
GB2375351B (en) Retrodifferentiation of cells to form undifferentiated cells
AU2002225997A1 (en) Two chamber cell culture vessel
HUP0201887A2 (en) Conditioned cell culture medium compositions and methods of use
AU2001280767A1 (en) Peptide-mediated delivery of molecules into cells
AU2001267475A1 (en) Combinations of Enzyme Inhibitor-Containing Preparations and the use thereof
AU2001245267A1 (en) Convertible patient isolation pod
AU1478000A (en) (in utero) transplantation of human mesenchymal stem cells
AU2002357079A1 (en) Expression of lysosomal hydrolase in cells expressing pro-n-acetylglucosamine-1-phosphodiester alpha-n-acetyl glucosimanidase
AU2001262697A1 (en) Method of amplifying natural killer t cells
AU2002235168A1 (en) Targeting pluripotent stem cells to tissues
AU2003280687A1 (en) Composition for culturing multipotent stem cells and utilization of the same
AU2001247880A1 (en) Methods to prepare and use epidermal stem cells
AU2002222238A1 (en) Co-culture of hepatocytes and stellate cells
AU2001275897A1 (en) Improvement of cell culture performance
AU2003299914A1 (en) Isolation and identification of cross-reactive t cells
AU2002213174A1 (en) Treatment of apoptotic cell death
WO2002040504A8 (en) Sol-fusin: use of gp64-6his to catalyze membrane fusion
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2002224383A1 (en) Method and marker for the isolation of human multipotent hematopoietic stem cells
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU4774200A (en) Long term cell culture of human carcinoma